Literature DB >> 19399359

Incidence, clinical presentation and pathological features of benign sclerosing cholangitis of unknown origin masquerading as biliary carcinoma.

Takeo Fujita1, Motohiro Kojima, Naoto Gotohda, Shinichiro Takahashi, Toshio Nakagohri, Masaru Konishi, Atsushi Ochiai, Taira Kinoshita.   

Abstract

BACKGROUND: Benign obstructions of the liver hilum are occasionally encountered in surgically resected cases. Some of these cases are pathologically classified as benign sclerosing cholangitis and are not clearly categorized. This study aims to elucidate the clinicopathological features of benign sclerosing cholangitis of unknown origin.
METHODS: Patients who had undergone surgery of the proximal bile duct from 1993 to 2008 on suspicion of proximal bile carcinoma were evaluated, then their clinical presentation, histopathological and immunohistochemical findings were retrospectively analyzed.
RESULTS: One hundred seventy-six patients underwent surgery during this period. Of these, five patients were diagnosed with benign sclerosing cholangitis of unknown origin. All five patients were middle-aged with no history of autoimmune disease. One patient died of recurrent cholangitis after surgery. Histopathologically, lymphoplasmacytic infiltrations were observed in all five cases. Among them, the clinicopathological findings of one patient were compatible with IgG4-related sclerosing cholangitis, and the other two patients had unusual histopathological findings with prominent lymph follicular formation.
CONCLUSIONS: Although patients with benign sclerosing cholangitis of unknown origin comprise a heterogeneous population, they can be further classified into subgroups. The response to immunosuppressive therapy, long-term prognosis and histological morphology of the disease should be considered in order to classify these cases of sclerosing cholangitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19399359     DOI: 10.1007/s00534-009-0115-5

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  6 in total

Review 1.  Adenomyomatous hyperplasia of the extrahepatic bile duct: a systematic review of a rare lesion mimicking bile duct carcinoma.

Authors:  Keishi Sugimachi; Yohei Mano; Yoshihiro Matsumoto; Tomohiro Iguchi; Kenichi Taguchi; Terumasa Hisano; Rie Sugimoto; Masaru Morita; Yasushi Toh
Journal:  Clin J Gastroenterol       Date:  2021-01-05

2.  Klatskin-like lesions.

Authors:  M P Senthil Kumar; R Marudanayagam
Journal:  HPB Surg       Date:  2012-06-28

3.  Diagnosis of bile duct cancer by bile cytology: usefulness of post-brushing biliary lavage fluid.

Authors:  Shinya Sugimoto; Hiroyuki Matsubayashi; Hirokazu Kimura; Keiko Sasaki; Kaori Nagata; Sachiyo Ohno; Katsuhiko Uesaka; Keita Mori; Kenichiro Imai; Kinichi Hotta; Kohei Takizawa; Naomi Kakushima; Masaki Tanaka; Noboru Kawata; Hiroyuki Ono
Journal:  Endosc Int Open       Date:  2015-05-07

4.  Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report.

Authors:  Narongsak Rungsakulkij; Pattana Sornmayura; Penampai Tannaphai
Journal:  BMC Surg       Date:  2017-02-15       Impact factor: 2.102

5.  Rare case of idiopathic sclerosing cholangitis, which was difficult to distinguish from cholangiocarcinoma: A case report.

Authors:  Shunsuke Shichi; Takahiro Einama; Mayu Suzuki; Hiroki Matsui; Ryo Kanazawa; Kazuaki Shibuya; Takashi Suzuki; Fumihiko Matsuzawa; Kohei Nakachi; Taku Hashimoto; Nobuo Kondo; Hironori Abe; Akinobu Taketomi
Journal:  Exp Ther Med       Date:  2018-10-05       Impact factor: 2.447

6.  A Resected Case of Follicular Cholangitis That Was Positive on 18F-fluorodeoxyglucose-positron Emission Tomography.

Authors:  Takashi Kosone; Hitoshi Takagi; Satoshi Takakusagi; Takashi Hoshino; Yozo Yokoyama; Kazuko Kizawa; Kyoko Marubashi; Akira Watanabe; Kenichiro Araki; Norifumi Harimoto; Hayato Ikota; Ken Shirabe; Kenichi Harada; Satoru Kakizaki; Toshio Uraoka
Journal:  Intern Med       Date:  2020-05-23       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.